BioHealth News Archive
Illumina to buy Pacific Biosciences for $1.2 billion – MedCity News
One of the largest companies involved in next-generation sequencing technology is buying a rival that manufactures genomic analysis systems. {iframe}https://medcitynews.com/2018/11/illumina-to-buy-pacific-biosciences-for-1-2-billion/?utm_campaign=MCN%20Daily%20Top%20Stories&utm_source=hs_email&utm_medium=email&utm_content=67207174&_hsenc=p2ANqtz-_gIeks2fzLQ8FRpx7d9L7XPxOmP2Q5QLZWR8mmTzbqCWoL_UP-nj0JiZy3sCESBSAWQ74mUkXOD57st0uCJF571TWm1A&_hsmi=67207174{/iframe}
Read More
Biobuzz Directory – Baltimore’s Gemstone Biotherapeutics Poised to Transform Wound Care Market
In the U.S. alone, there are over 100 million chronic wound visits every year. By 2020, the general wound care market is expected to…
Read More
Inside 3675 Market, Philadelphia’s Newest Innovation Hub
On November 9th, 3675 Market Street will officially open its doors to the public about two years after its ceremonial groundbreaking. So far, the…
Read More
AbbVie Follows Trend of Big Pharma Setting Office-Labs in Biotech Clusters – BioSpace
In what appears to be a trend, big pharma company AbbVie is leasing 479,000 square feet of space in BioMed Realty’s Gateway of Pacific project in South San Francisco.…
Read More
PIC MC RISE Zone Celebration and Ribbon Cutting
The PIC MC Foundation Board of Directors invites you to celebrate a significant milestone in the development of PIC MC. Join us, along with…
Read More
Novavax Appoints Rachel King to Board of Directors – NASDAQ.com
Novavax, Inc., (Nasdaq:NVAX) today announced the appointment of Rachel King, Co-Founder and Chief Executive Officer of GlycoMimetics, Inc., to its Board of Directors. In…
Read More
CMS will cover virtual care for the first time – MedCity News
On November 1, the Centers for Medicare and Medicaid Services finalized changes to the 2019 Physician Fee Schedule and the Quality Payment Program. One of…
Read More
Johnson & Johnson Innovation Announces Extension of JJIPO @ QUT in Collaboration with Queensland State Government to Further Boost Life-Science Innovation in Queensland | Business Wire
Johnson & Johnson Innovation announced the extension of the Johnson & Johnson Innovation Partnering Office at Queensland University of Technology (JJIPO @ QUT) for…
Read More
FounderTrac Demo Day
Tuesday ,November 6, 2018 6:15 PM - 8:30 PM, Hotel Annapolis126 West StreetAnnapolis, MD 21401 FounderTrac invites you to Demo Day! The FounderTrac accelerator ‘connects…
Read More
OpGen Collaborates With QIAGEN to Advance Rapid Diagnostics for Antimicrobial Resistant Bacteria Nasdaq:OPGN
OpGen, Inc. (NASDAQ: OPGN) today announced a collaboration with QIAGEN N.V. to advance rapid diagnostics for antimicrobial resistance (AMR). Strengthening OpGen’s entry into the…
Read More
TaiRx looks to commercialize therapy targeting drug-resistant cancers – Washington Business Journal
TaiRx, a joint venture between Rockville-based BioHealth Innovation Inc. and Taiwan pharmaceutical company TaiRx Inc., is looking to raise around $5 million. {iframe}https://www.bizjournals.com/washington/news/2018/10/31/how-maryland-s-newest-company-plans-to-take-down.html{/iframe}
Read More
Washington Business Journal Recognizes Emmes in Two “Top Company” Lists
The Emmes Corporation today announced that it was named one of the largest women-owned businesses in the Washington metropolitan area by the Washington Business…
Read More
Here’s how an AstraZeneca spinout deal gets done – Baltimore Business Journal
AstraZeneca PLC’s research and development arm MedImmune Inc. spun off a small biotech startup company called Viela Bio. {iframe}https://www.bizjournals.com/baltimore/news/2018/10/30/here-s-how-an-astrazeneca-spinout-deal-gets-done.html{/iframe}
Read More
What’s next for RightEye following FDA approval – Washington Business Journal
Bethesda health tech company RightEye LLC is finally moving beyond the research and development phase. {iframe}https://www.bizjournals.com/washington/news/2018/10/30/righteye-got-its-fda-approval-here-s-what-s-next.html?ana=e_du_prem&s=article_du&ed=2018-10-30&u=fQFLvOpMSMnvK7iAcBsVng0eb45ba2&t=1541423895&j=84729071{/iframe}
Read More
Alexandria Real Estate’s Marcus on Interest Rates, Drug Pricing – Bloomberg
Joel Marcus, chairman at Alexandria Real Estate Equities, discusses the risk of rising interest rates, how government action on drug pricing could impact the…
Read More